A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis

Author:

Konstan, M. W.; Doering, G.; Heltshe, S. L.; Lands, L. C.; Hilliard, K. A.; Koker, P.; Bhattacharya, S.; Staab, A.; Hamilton, A.

Tübinger Autor(en):

Published in:

Journal of Cystic Fibrosis (2014), Bd. 13, H. 2, S. 148-155

Verlagsangabe:

Elsevier Science Bv

Language:

English

Full text:

ISSN:

1569-1993

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)